Ian Freelance (Chairman): has a broad experience within the life science industry covering biotech, medtech and nutritional ingredients. He has been with DSM Venturing since 2008. He is currently a board member of Regentis, UpFront, SolGel, BioProcess Control, SkySails as well as a US Medtech.. He studied Chemistry at the University of Sheffield in the UK .
Dharminder Chahal : has built an extensive network in the life science industry and a strong track record in complex corporate transactions. As a CEO, board member or advisor he is active for several European companies such as SkylineDx, CardioGenx, BioInvent, VitalneXt, BioGeneration Ventures II, Thuja Capital Fund I, Gilde Healthcare Funds II and III and Innate Pharma.
Wim Jongen Ph.D.: has a broad experience in the assessment of technology and intellectual properties within the life science and biotech industry. Mr. Jongen was the Director of the Wageningen Business Generator BV and held several senior managerial positions at Wageningen UR. He was a Professor in Food Product Design and Quality Management at Wageningen University. He serves as the Chairman of the Board of Directors at Pepscan Holding NV and a number of life sciences companies. He is Author of more than 150 scientific papers and has edited and/or written seven scientific books. He has a background in toxicology and food science and over 15 years of experience in business development in the life sciences. Mr. Jongen obtained a Ph.D. in Toxicology at Wageningen University in 1988.